Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT) (ZU-HVA-001)

University of Zurich (UZH)

Status: Completed

Conditions: Hymenoptera Sting Allergy

Treatments: Other: Observation

Study type: Observational

Funder types: Other

Identifiers

NCT00742794

ZU-HVA-001

Details and patient eligibility

About

In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Enrollment: 200 estimated patients

Sex: All

Ages: 5 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Bee and/or Wasp allergic patients treated by SIT

Exclusion criteria

• None

Trial design

200 participants in 1 patient group

1

Description:

Hymenoptera sting allergic patients under immunotherapy

Treatment:

Other: Observation